Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products
Identifieur interne : 002F94 ( Main/Merge ); précédent : 002F93; suivant : 002F95Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products
Auteurs : Jay P. Brooks [États-Unis]Source :
- Transfusion [ 0041-1132 ] ; 2005-10.
English descriptors
- Teeft :
- Aabb, Biometrics, Blood centers, Blood donor centers, Blood product, Blood products, Blood safety, Blood supply, Blood transfusion, Code technology, Error detection, Fatality, Hospital personnel, Hospital transfusion, Internet, October, Privacy concerns, Proper patient, Rbc, Reengineering, Rfid, Supplement transfusion, Transfusion, Transfusion activities, Transfusion errors, Transfusion medicine, Transfusion medicine service, Transfusion medicine services, Transfusion process, Transfusion safety, Transfusion service, Transfusion volume, Vpta.
Abstract
Efforts to make blood transfusion as safe as possible have focused on making the blood in the bag as disease‐free as possible. The results have been dramatic, and the costs have been correspondingly high. Although blood services will have to continue to deal with emerging pathogens, efforts to reduce the transfusion of infectious agents presently posing a risk will require high incremental costs and result in only improvements of a small magnitude. The other aspect of safe blood transfusion, the actual transfusion process performed primarily in hospitals, has been accorded considerably less interest. We should turn our attention to enhancing overall blood safety by focusing on improving the process of blood transfusion. Errors involving patient, specimen, and blood product identification put transfused patients at risk, increasing the mortality risk for some. Solutions that could improve the transfusion process are discussed as a focus of this article.
Url:
DOI: 10.1111/j.1537-2995.2005.00617.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000614
- to stream Istex, to step Curation: 000614
- to stream Istex, to step Checkpoint: 000A76
Links to Exploration step
ISTEX:6DC9FA5DBE6F9BBBDB2AD1E9E31913B74E051A0CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products</title><author><name sortKey="Brooks, Jay P" sort="Brooks, Jay P" uniqKey="Brooks J" first="Jay P." last="Brooks">Jay P. Brooks</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6DC9FA5DBE6F9BBBDB2AD1E9E31913B74E051A0C</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1537-2995.2005.00617.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-DBL22D34-Z/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000614</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000614</idno><idno type="wicri:Area/Istex/Curation">000614</idno><idno type="wicri:Area/Istex/Checkpoint">000A76</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A76</idno><idno type="wicri:doubleKey">0041-1132:2005:Brooks J:reengineering:transfusion:and</idno><idno type="wicri:Area/Main/Merge">002F94</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products</title><author><name sortKey="Brooks, Jay P" sort="Brooks, Jay P" uniqKey="Brooks J" first="Jay P." last="Brooks">Jay P. Brooks</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Oklahoma</region></placeName><wicri:cityArea>From the University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Oklahoma</region></placeName><wicri:cityArea>Correspondence address: Jay P. Brooks, MD, MBA, Associate Professor of Pathology, Director of Transfusion Medicine, University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Transfusion</title><title level="j" type="alt">TRANSFUSION</title><idno type="ISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">s4</biblScope><biblScope unit="page" from="159S">159S</biblScope><biblScope unit="page" to="171S">171S</biblScope><biblScope unit="page-count">13</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-10">2005-10</date></imprint><idno type="ISSN">0041-1132</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-1132</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Aabb</term><term>Biometrics</term><term>Blood centers</term><term>Blood donor centers</term><term>Blood product</term><term>Blood products</term><term>Blood safety</term><term>Blood supply</term><term>Blood transfusion</term><term>Code technology</term><term>Error detection</term><term>Fatality</term><term>Hospital personnel</term><term>Hospital transfusion</term><term>Internet</term><term>October</term><term>Privacy concerns</term><term>Proper patient</term><term>Rbc</term><term>Reengineering</term><term>Rfid</term><term>Supplement transfusion</term><term>Transfusion</term><term>Transfusion activities</term><term>Transfusion errors</term><term>Transfusion medicine</term><term>Transfusion medicine service</term><term>Transfusion medicine services</term><term>Transfusion process</term><term>Transfusion safety</term><term>Transfusion service</term><term>Transfusion volume</term><term>Vpta</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Efforts to make blood transfusion as safe as possible have focused on making the blood in the bag as disease‐free as possible. The results have been dramatic, and the costs have been correspondingly high. Although blood services will have to continue to deal with emerging pathogens, efforts to reduce the transfusion of infectious agents presently posing a risk will require high incremental costs and result in only improvements of a small magnitude. The other aspect of safe blood transfusion, the actual transfusion process performed primarily in hospitals, has been accorded considerably less interest. We should turn our attention to enhancing overall blood safety by focusing on improving the process of blood transfusion. Errors involving patient, specimen, and blood product identification put transfused patients at risk, increasing the mortality risk for some. Solutions that could improve the transfusion process are discussed as a focus of this article.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002F94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:6DC9FA5DBE6F9BBBDB2AD1E9E31913B74E051A0C
|texte= Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products
}}
| This area was generated with Dilib version V0.6.33. |  |